Resultados de la búsqueda 31-40 of 15316 for Adhesion

  1. Programa de tumores cerebrales - Ensayos clínicos - Mayo Clinic

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

  2. Neurología - Ensayos clínicos - Mayo Clinic

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

  3. Programa de tumores cerebrales - Ensayos clínicos - Mayo Clinic

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

  4. Neurología - Ensayos clínicos - Mayo Clinic

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

  7. Neurología - Ensayos clínicos - Mayo Clinic

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...